{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-160293","form_type":"8-K","ticker":"RPRX","cik":"0001802768","company_name":"Royalty Pharma plc","filed_at":"2025-07-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.041461+00:00","generated_at":"2026-05-18T05:59:35.082029+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Royalty Pharma appoints Carole Ho and Elizabeth Weatherman to Board of Directors","bullets":["Carole Ho (CMO of Denali Therapeutics) and Elizabeth Weatherman (Special LP at Warburg Pincus) appointed effective July 17, 2025.","Independent board representation increases to >90% following external manager acquisition.","Both directors determined independent under Nasdaq standards; no family relationships with officers or directors.","They will receive compensation per Independent Director Compensation Policy detailed in April 2025 Proxy Statement."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-160293","json":"https://secwatch.observer/filing/0001193125-25-160293.json","markdown":"https://secwatch.observer/filing/0001193125-25-160293.md","text":"https://secwatch.observer/filing/0001193125-25-160293.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1802768/000119312525160293/0001193125-25-160293-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1802768/000119312525160293/d948144d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T05:59:35.082029+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}